Snowball Research

Snowball Research

Share this post

Snowball Research
Snowball Research
Iroquois Capital Nominates Slate Of Highly Qualified Director Candidates For Election At Pharma Cyte’s 2022 Annual Meeting
Copy link
Facebook
Email
Notes
More

Iroquois Capital Nominates Slate Of Highly Qualified Director Candidates For Election At Pharma Cyte’s 2022 Annual Meeting

Jun 23, 2022
∙ Paid

Share this post

Snowball Research
Snowball Research
Iroquois Capital Nominates Slate Of Highly Qualified Director Candidates For Election At Pharma Cyte’s 2022 Annual Meeting
Copy link
Facebook
Email
Notes
More
Share

Dear Fellow PharmaCyte Biotech Stockholders:

As previously communicated, Iroquois Capital Management, LLC (together with its affiliates, “Iroquois”) currently owns approximately 6.1% of the outstanding shares of PharmaCyte Biotech, Inc. (“PharmaCyte” or the “Company”), making us one of the Company’s largest stockholders.

We invested in the Company in Augu…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Snowball Research | March Intelligence Research LLP
Publisher Terms
Substack
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More